Cyclopentolate Hydrochloride has 3 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Carbachol, Mao Inhibitors, Pilocarpine Hydrchloride. Patients taking Cyclopentolate Hydrochloride should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 3
- Moderate
- 3
Moderate (3)
- Cyclopentolate Hydrochloride + Carbachol— Cyclopentolate may interfere with the ocular anti-hypertensive action of carbachol.
- Cyclopentolate Hydrochloride + Mao Inhibitors— Cyclopentolate may interfere with the ocular anti-hypertensive action of ophthalmic cholinesterase inhibitors.
- Cyclopentolate Hydrochloride + Pilocarpine Hydrchloride— Cyclopentolate may interfere with the ocular anti-hypertensive action of pilocarpine.